Blog

NEW JUVEDERM VOLITE IN STOCK AT ANNA’S COSMETICS

Buy Juvederm Online

Allergan Launches Juvéderm VOLITE – an Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months!

Allergan brought out a new injectable – Juvéderm VOLITE.

Juvéderm VOLITE is manufactured using the same VYCROSS technology as Juvéderm VOLUMA, Juvéderm VOLBELLA and Juvéderm VOLIFT, however, its main indication is not filling of lines and wrinkles, but improvement of the skin quality – global research shows more than 50% of women believe appearance and condition of their skin contributes to their beauty.

Juvéderm VOLITE was designed to improve skin’s smoothness, hydration and elasticity for up to nine months with just one treatment, eliminating the need for multiple treatments and delivering results that last. It can be used to treat the face, neck, décolletage and hands. Like all the product within VYCROSS range, Juvéderm VOLITE contains lidocaine to enhance patients comfort.

At Anna’s Cosmetics, we believe that Juvéderm VOLITE answers a real need for a treatment that delivers a healthy-looking glow. Considering that only one treatment is needed to achieve results, this product will be a game changer for our shop and all our customers because great skin has a strong impact on our everyday lives, in particular our self-confidence. It goes far beyond aesthetics – when we are happy with how we look on the outside, this affects how we feel on the inside.

Juvéderm VOLITE delivers improvements on a range of skin quality components including smoothness (absence of fine lines), hydration and elasticity. In a clinical trial of 131 patients, the clinical study showed an improvement in skin quality at one, four and six months. One month after treatment, 96% of patients’ cheeks had much less fine lines and wrinkles and 91% of patients reported they were very satisfied with their skin appearance. Results were sustained at six months, where patients reported that they continued to see significant improvements in skin hydration. The final study results should be published during April 2017.

Leave a Reply

Your email address will not be published. Required fields are marked *